Evaluation of 308-nm monochromatic excimer light in the treatment of psoriasis vulgaris and palmoplantar psoriasis

Photodermatology Photoimmunology and Photomedicine

Volumn 24, Issue 5, 2008, Pages 231-236

  Han, Ling ^a   Somani, Ally Khan ^b   Huang, Qiong ^a   Fang, Xu ^a   Jin, Yi ^a   Xiang, Lei Hong ^a   Zheng, Zhi Zhong ^a  

^a FUDAN UNIVERSITY   (China)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

308 nm; Monochromatic excimer light; Phototherapy; Psoriasis

Indexed keywords

ADULT; AGED; ARTICLE; BLISTER; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DISEASE SEVERITY; ERYTHEMA; EXCIMER LASER; FEMALE; HUMAN; INCIDENCE; MALE; PRIORITY JOURNAL; PRURITUS; PSORIASIS VULGARIS; PUSTULOSIS PALMOPLANTARIS; SAFETY; SCORING SYSTEM; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; HUMANS; LASER THERAPY; MALE; MIDDLE AGED; PSORIASIS; ULTRAVIOLET RAYS;

EID: 51949113189     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2008.00364.x     Document Type: Article

References (16)

1. Honigmann H, Szeimies RM, Knobler R, et al. Photochemotherapy and photodynamic therapy. In: Freedberg IM, Eisen AZ, Wolff K, et al., eds. Dermatology in general medicine. New York: McGraw-Hill, 1999; 2880-2900.
2. Neumann NJ, Mahnke N, Korpusik D, Stege H, Ruzicka T. Treatment of palmoplantar psoriasis with monochromatic excimer light (308-nm) versus cream PUVA. Acta Derm Venereol 2006; 86: 22-24.
3. Green C, Ferguson J, Lakshmipathi T, Johnson BE. 311 nm UVB phototherapy - an effective treatment for psoriasis. Br J Dermatol 1988; 119: 691-696.
4. Parrish JA. Phototherapy and photochemotherapy of skin diseases 46. J Invest Dermatol 1981; 77: 167-171.
5. He YL, Zhang XY, Dong J, Xu JZ, Wang J. Clinical efficacy of a 308 nm excimer laser for treatment of psoriasis vulgaris. Photodermatol Photoimmunol Photomed 2007; 23: 238-241.
6. Mavilia L, Campolmi P, Rossi R, Mori M, Pimpinelli N, Cappugi P. Wide-area 308-nm phototherapy with nonlaser light in the treatment of psoriasis: Results of a pilot study. Br J Dermatol 2005; 152: 1376-1377.
7. Aubin F, Vigan M, Puzenat E, et al. Evaluation of a novel 308-nm monochromatic excimer light delivery system in dermatology: A pilot study in different chronic localized dermatoses. Br J Dermatol 2005; 152: 99-103.
8. Kollner K, Wimmershoff MB, Hintz C, Landthaler M, Hohenleutner U. Comparison of the 308-nm excimer laser and a 308-nm excimer lamp with 311-nm narrowband ultraviolet B in the treatment of psoriasis. Br J Dermatol 2005; 152: 750-754.
9. Bianchi B, Campolmi P, Mavilia L, Danesi A, Rossi R, Cappugi P. Monochromatic excimer light (308 nm): An immunohistochemical study of cutaneous T cells and apoptosis-related molecules in psoriasis. J Eur Acad Dermatol Venereol 2003; 17: 408-413.
10. Hofer A, Fink-Puches R, Kerl H, Quehenberger F, Wolf P. Paired comparison of bathwater versus oral delivery of 8-methoxypsoralen in psoralen plus ultraviolet: A therapy for chronic palmoplantar psoriasis. Photodermatol Photoimmunol Photomed 2006; 22: 1-5.
11. Campolmi P, Mavilia L, Lotti TM, Rossi R, Brazzini B, Hercogova J. 308 nm monochromatic excimer light for the treatment of palmoplantar psoriasis. Int J Immunopathol Pharmacol 2002; 13: 11-13.
12. Cappugi P, Mavilia L, Mavilia C, Campolmi P, Lotti TM. 308 nm monochromatic excimer light in psoriasis. Clinical evaluation and study of cytokine levels in the skin. Int J Immunopathol Pharmacol 2002; 13: 14-19.
13. Nistic SP, Saraceno R, Stefanescu S, Chimenti S. A 308-nm monochromatic excimer light in the treatment of palmoplantar psoriasis. J Eur Acad Dermatol Venereol 2006; 20: 523-526.
14. Gerber W, Arheilger B, Ha TA, Hermann J, Ockenfels HM. Ultraviolet B 308-nm excimer laser treatment of psoriasis: A new phototherapeutic approach. Br J Dermatol 2003; 149: 1250-1258.
15. Feldman SR, Mellen BG, Housman TS, et al. Efficacy of the 308-nm excimer laser for treatment of psoriasis: Results of a multicenter study. J Am Acad Dermatol 2002; 46: 900-906.
16. Carlin CS, Feldman SR, Krueger JG, Menter A, Krueger GG. A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis 1. J Am Acad Dermatol 2004; 50: 859-866.